Related Experiment Videos
[Pregnancy complicated with thrombocytopenia].
Anna Grzyb1, Krzysztof Rytlewski, Agnieszka Domanska
1Uniwersytet Jagiellońiski Collegium Medicum, Katedra Ginekologii i Poloznictwa. goroka@poczta.onet.pl
Ginekologia Polska
|January 16, 2007
Summary
Severe thrombocytopenia in pregnancy significantly increases risks for preterm labor, lower Apgar scores, and neonatal complications. Early detection and management are crucial for maternal and infant well-being.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Neonatology
Context:
- Thrombocytopenia, a condition characterized by low platelet counts, can complicate pregnancy.
- Understanding the impact of different types and severities of thrombocytopenia is vital for optimizing obstetric and neonatal care.
Purpose:
- To evaluate how thrombocytopenia type and platelet count influence pregnancy outcomes.
- To assess effects on maternal and neonatal health, including delivery mode, complications, and infant well-being.
Summary:
- A retrospective study of 45 women with thrombocytopenia revealed that severe cases were linked to higher rates of preterm labor (42.85%) compared to moderate cases (16.13%).
- Severe thrombocytopenia correlated with lower birth weights, reduced Apgar scores, and increased neonatal complications (71.42%) versus moderate cases (28.58%).
- Presence of antiplatelet antibodies and platelet counts below 50 x 10(3)/MICROL necessitated maternal steroid treatment and platelet transfusions, and was associated with adverse neonatal outcomes.
Impact:
- Findings highlight the critical association between severe thrombocytopenia and adverse pregnancy and neonatal outcomes.
- This research underscores the importance of vigilant monitoring and timely intervention for pregnant individuals with thrombocytopenia.
- Improved management strategies based on thrombocytopenia severity can potentially mitigate risks for both mother and child.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...